GGrantIndex
Sort

130,381 grants matching hiv

Next generation hybrid nucleases for precise excision of latent HIV-1 provirus

$937,745
Jeremy Luban · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI

Systems biology of HIV, methamphetamine and antiretrovirals interactions

$937,707
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2016 · DA

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs

$937,669
Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center: Husbandry and Management Core

$937,467
Joyce Kimberly Cohen · Emory University · U42 · FY2020 · OD

Clinical Trials Network: Greater New York Node

$937,369
Edward V Nunes · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · U10 · FY2011 · DA

ADOLESCENT MEDICINE TRIALS UNIT (AMTU)

$937,358
Mount Sinai School Of Medicine Of Nyu · U01 · FY2005 · HD

Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)

$937,335
Philip Todd Korthuis · Oregon Health & Science University · U01 · FY2023 · TR

Comparison of Bayesian and Frequentist Methods in Cardiovascular Clinical Trials

$937,264
Alice Rogot Pressman · Kaiser Foundation Research Institute · RC4 · FY2010 · HL

WHICH ISOTYPE OF ECD4-IG MOST EFFECTIVELY SUPPRESSES VIRUS REPLICATION?

$937,245
Michael David Alpert · Emmune, Inc · R44 · FY2017 · AI

Elucidating the Regulation of HIV RNA Functions: Translation Genome Packaging

$937,186
Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Defining Mechanisms of HIV-1 Gag:RNA Interactions and Virus Assembly

$937,186
Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Mental health disorders in a sexual minority population

$936,974
University Of California Los Angeles · R01 · FY2003 · DA

Clinical Core

$936,892
Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2015 · AI

Maximizing germinal centers and somatic hypermutation to HIV Env immunogens

$936,822
Shane P Crotty · La Jolla Institute For Immunology · R01 · FY2016 · AI

Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP

$936,750
Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

X-ray Crystallographic Fragment Screening Core

$936,551
Edward V Arnold · Scripps Research Institute, The · U54 · FY2018 · GM

Sialic acid analogs against multidrug-resistant gonorrhea

$936,377
Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI

Understanding and Preventing Childhood Drug Use Risk

$936,293
Thomas J Dishion · University Of Oregon · R01 · FY2008 · DA

Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals

$936,265
Richard E Chaisson · Johns Hopkins University · U01 · FY2021 · AI

Novel Model for HIV Latency in Primary Memory T Cells

$936,050
Eric M Verdin · J. David Gladstone Institutes · DP1 · FY2014 · DA

Novel Model for HIV Latency in Primary Memory T Cells

$936,050
Eric M Verdin · J. David Gladstone Institutes · DP1 · FY2011 · DA

Novel Model for HIV Latency in Primary Memory T Cells

$936,050
Eric M Verdin · J. David Gladstone Institutes · DP1 · FY2012 · DA

Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing

$936,026
Katharine June Bar · University Of Pennsylvania · R01 · FY2023 · MH

RNAi Screening in Hematopoietic Cells

$935,970
Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS

$935,922
Patrick J Loehrer · Indiana University Indianapolis · U54 · FY2021 · CA